• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Patients feel the pinch of higher generic drug prices

Quote

Anonymous

Guest
"Generic drugs are supposed to be easy to get and cheap. But recently, the price of some generic drugs has doubled, tripled, or even quadrupled. And now, patients are starting to feel the pinch."

You knew it was just a matter of time in a sometimes wide open generic field as brand domination diminishes.
 

<



Anonymous said:
"Generic drugs are supposed to be easy to get and cheap. But recently, the price of some generic drugs has doubled, tripled, or even quadrupled. And now, patients are starting to feel the pinch."

You knew it was just a matter of time in a sometimes wide open generic field as brand domination diminishes.
Click to expand...

AZ is going to be a generics company if it survives the upcoming expiries. What else are they going to do, with no new products?
 




Similar threads

“We put patients first” vs Ridealong
Replies
15
Views
3K
AstraZeneca
anonymous
Patients on Invokana are getting free prosthetic Toes and Limbs
Replies
7
Views
1K
AstraZeneca
anonymous
Diabetes portfolio bad for patients
Replies
7
Views
2K
AstraZeneca
Anonymous
No more cash and medicare patients for coupons
Replies
1
Views
3K
AstraZeneca
Anonymous
If the price is right, the patients can die! Sack this guy first
Replies
0
Views
647
AstraZeneca
Anonymous
Top Bottom
Back
Quote